drugset / Trial / NCT04978025

Colloidal Silver, Treatment of COVID-19

NCT04978025

Unknown 50 enrolled Hôpital Universitaire Sahloul
RandomizedParallel-groupTriple-blindTreatment

Summary

Noble metals such as gold and silver have been appreciated for millennia not only for their beauty but also for their ability to fight diseases. Silver nanoparticles (AgNPs) have been employed as chemical drugs thanks to their unique physiochemical and chemical properties as well as biological features, such as anti-inflammatory, anti-angiogenesis, antiplatelet, antifungal, anti-cancer and antibacterial activities I

Timeline

Start
2020-11-01
Primary completion
2021-11-01
Completion
2021-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Silver nanoparticles Unknown 5 ml Oral
Subject Silver nanoparticles Unknown 30 ml Oral